Abstract
Since its birth in the late 1980s, the field of microfluidics has continued to mature, with a growing number of companies pursuing diagnostic applications. In 2009 the worldwide in vitro diagnostics market was estimated at >$40 billion USD, and microfluidic diagnostics are poised to reap a significant part of this market across a range of areas including laboratory diagnostics, point-of-care diagnostics, cancer diagnostics, and others. The potential economic advantages of microfluidics are numerous and compelling: lower reagent and/or sample volumes, lower equipment costs, improved portability, increased automation, and increased measurement speed. All of these factors may help put more information in the hands of doctors and patients sooner, enabling earlier disease detection and more tailored, effective treatments. This chapter reviews the microfluidic diagnostics commercial landscape and discusses potential commercialization challenges and opportunities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kalorama Information: In Vitro Diagnostics Market Doubled Over Decade: Kalorama Reports. http://www.kaloramainformation.com/about/release.asp?id=1771. Accessed 12 Nov 2012
Sklar LA, Carter MB, Edwards BS (2007) Flow cytometry for drug discovery, receptor pharmacology and high throughput screening. Curr Opin Pharmacol 7:527–534
Maheswaran S, Haber DA (2010) Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev 20:96–99
Home—ClinicalTrials.gov. http://clinicaltrials.gov/. Accessed 12 Nov 2012
On-Q-ity: Diagnose, Monitor, Save. http://www.on-q-ity.com/publications/. Accessed 12 Nov 2012
Nagrath S et al (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235–1239
Company Description—Biocept Website. http://www.biocept.com/. Accessed 12 Nov 2012
Cytoscale Website. http://cytoscale.com/. Accessed 25 Oct 2010
Superior NanoBioSystems—Home. http://www.superiornanobiosystems.com/index.html. Accessed 12 Nov 2012
Near patient microfluidic rare cell detection: a paradigm shift in flow cytometry. http://www.cli-online.com/index.php?id=1024&tx_ttproducts_pi1(product)=2714&swords=near%20patient%20gerdes. Accessed 12 Nov 2012
Lancaster C et al (2005) Rare cancer cell analyzer for whole blood applications: microcytometer cell counting and sorting subcircuits. Methods 37:120–127
Micronics Microfluidics: Lab Automation & Nanotechnology. http://www.micronics.net/technology. Accessed 12 Nov 2012
Veridex, LLC, a Johnson & Johnson company in vitro diagnostics oncology. http://www.veridex.com/cellsearch/CellSearchHCP.aspx. Accessed 12 Nov 2012
Sequist LV et al (2009) The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients. J Thorac Oncol 4:281–283
Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital. http://www.jnj.com/connect/news/all/veridex-llc-announces-collaboration-to-develop-next-generation-circulating-tumor-cell-technology-with-massachusetts-general-hospital. Accessed 12 Nov 2012
Welcome to Artemis Health—Our mission is to develop tests that provide accurate and timely information about fetal and maternal health. http://www.verinata.com/. Accessed 12 Nov 2012
StreetInsider.com—Canaccord Adams Raises Price Target On Inverness Medical (IMA) to $49, Citing Pima System. http://www.streetinsider.com/Analyst+Comments/Canaccord+Adams+Raises+Price+Target+On+Inverness+Medical+(IMA)+to+$49,+Citing+Pima+System/4974389.html. Accessed 12 Nov 2012
Daktari Diagnostics, Inc. http://www.daktaridx.com/. Accessed 12 Nov 2012
Daktari Diagnostics, Backed by Gates Foundation, Raises Funds for HIV Test Study | Xconomy. http://www.xconomy.com/boston/2010/06/17/daktari-diagnostics-backed-by-gates-foundation-raises-funds-for-hiv-test-study/. Accessed 12 Nov 2012
University Funding and Grants | Scientific Frontline Communication Center. HIV treatment test closer to manufacture with new $7.3 million grant. http://www.sflorg.com/comm_center/unv_funding/. 12 Nov 2012
Daktari Diagnostics, Backed by Gates Foundation, Raises Funds for HIV Test Study | Xconomy. http://www.xconomy.com/boston/2010/06/17/daktari-diagnostics-backed-by-gates-foundation-raises-funds-for-hiv-test-study/. Accessed 12 Nov 2012
PIMA: Home. http://pimatest.com/en/home.html. Accessed 12 Nov 2012
Mtapuri-Zinyowera S et al (2010) Evaluation of the PIMA Point-of-Care CD4 Analyzer in VCT Clinics in Zimbabwe. J Acquir Immune Defic Syndr 55:1–7
i-STAT® System | Point-of-Care Testing | Handheld Blood Analyzer | Abbott Point of Care.com. http://www.abbottpointofcare.com/. Accessed 12 Nov 2012
SEC Info—I Stat Corporation/DE—10-K—For 12/31/02. http://www.secinfo.com/dqtWy.29.htm#ecri. Accessed 12 Nov 2012
Abaxis—Home. http://www.abaxis.com/index.asp. Accessed 12 Nov 2012
FSB 100: Top Small Businesses—Abaxis Inc. (ABAX)—FORTUNE Small Business. http://money.cnn.com/magazines/fsb/fsb100/2009/snapshots/45.html. Accessed 12 Nov 2012
Siemens Global Website. http://www.siemens.com/entry/cc/en/. Accessed 12 Nov 2012
I-Micronews—MICROFLUIDICS: Samsung ventures into medical device market. http://www.i-micronews.com/lectureArticle.asp?id=5168. Accessed 12 Nov 2012
Welcome to the Medical Device Space Samsung. http://www.medgadget.com/archives/2010/07/welcome_to_the_medical_device_space_samsung_1.html. Accessed 12 Nov 2012
Claros Diagnostics—Corporate Overview. http://www.opko.com/. Accessed 22 Aug 2010
Prostate Cancer Results While You Wait—Technology Review. http://www.technologyreview.com/printer_friendly_article.aspx?id=24932. Accessed 12 Nov 2012
BVGH Reports | Global Health R&D | BIO Ventures for Global Health (BVGH). http://www.bvgh.org/Biopharmaceutical-Solutions/Data-Center/BVGH-Reports.aspx. Accessed 14 June 2011
Diagnostics For All. http://www.dfa.org/. Accessed 12 Nov 2012
Posthuma-Trumpie GA, Korf J, Amerongen A (2008) Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey. Anal Bioanal Chem 393:569–582
Inverness stays in acquisition mode | IVD Technology. http://www.ivdtechnology.com/article/inverness-stays-acquisition-mode. Accessed 12 Nov 2012
Halperin A (2007, March 26) A Hefty Price for Biosite. BusinessWeek: http://www.businessweek.com/stories/2007-03-26/a-hefty-price-for-biositebusinessweek-business-news-stock-market-and-financial-advice Accessed 06 Oct 2012
Inverness completes Biosite acquisition—Daily Business Update—The Boston Globe. http://www.boston.com/business/ticker/2007/06/inverness_compl.html. Accessed 12 Nov 2012
Biosite agrees to Inverness acquisition for $92.5 per share—Mass High Tech Business News. http://www.masshightech.com/stories/2007/05/14/daily39-Biosite-agrees-to-Inverness-acquisition-for-925-per-share.html. Accessed 12 Nov 2012
Biosite® Inc. Web Site—Products. http://www.alere.com/us/en.html. Accessed 29 Nov 2010
Quanterix—The Leader in Single Molecule Analysis. http://www.quanterix.com/. Accessed 12 Nov 2012
Rissin DM et al (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28:595–599
Boston Microfluidics. http://www.bostonmicrofluidics.com/. Accessed 12 Nov 2012
Plexigen. http://www.plexigen.com/. Accessed 30 Nov 2010
Fitzgerald SP et al (2005) Development of a high-throughput automated analyzer using biochip array technology. Clin Chem 51:1165–1176
Randox Laboratories. http://www.randox.com/index.php. Accessed 12 Nov 2012
Better ImmunoAssays through Innovative Microfluidics—Siloam Biosciences. https://www.siloambio.com/. Accessed 12 Nov 2012
Davies K (2010) The $1,000 Genome: The revolution in DNA sequencing and the new era of personalized medicine simon and schuster
The $30 Genome?—Technology Review. http://technologyreview.com/biomedicine/25481/?mod=related. Accessed 12 Nov 2012
GnuBio Enters Next-Generation Sequencing Sweepstakes—Bio-IT World. http://www.bio-itworld.com/news/06/02/10/Gnubio-sequencing-debut-consumer-genetics.html. Accessed 12 Nov 2012
GnuBIO ahead of schedule with DNA sequencing plans—Mass High Tech Business News. http://www.masshightech.com/stories/2011/06/06/daily22-GnuBIO-ahead-of-schedule-with-DNA-sequencing-plans.html. Accessed 12 Nov 2012
Cepheid | GeneXpert System. http://www.cepheid.com/systems-and-software/genexpert-system/. Accessed 12 Nov 2012
Boehme CC et al (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363:1005–1015
Small PM, Pai M (2010) Tuberculosis diagnosis—time for a game change. N Engl J Med 363:1070–1071
Automated Test for Drug-Resistant Tuberculosis Gives Results in Hours—NYTimes.com. http://www.nytimes.com/2010/09/07/health/07global.html. Accessed 12 Nov 2012
Cepheid Reports Record Revenue of $44.8 Million—FierceHealthcare. http://www.fiercehealthcare.com/press-releases/cepheid-reports-record-revenue-44-8-million. Accessed 12 Nov 2012
NORCHIP. http://www.norchip.com/. Accessed 12 Nov 2012
Future Science News and Analysis. Cancer Screening Made Simple, Thanks to Micro-Fluidic Technology —Science Daily. http://www.sciencedaily.com/releases/2010/10/101014113914.html. Accessed 06 Oct 2012
Biolithic | Consumer Diagnostic Devices. http://www.biolithic.com/. Accessed 12 Nov 2012
Magna Diagnostics. http://magnadiagnostics.com/. Accessed 12 Nov 2012
Shoveling Water—Technology Review. http://www.technologyreview.com/biomedicine/24086/. Accessed 12 Nov 2012
Abe Lee tells Kathleen Too about the fundamentals of micro- and nanofluidics and lab-on-a-chip devices. http://www.rsc.org/Publishing/ChemTech/Volume/2009/05/Abe_Lee_interview.asp. Accessed 12 Nov 2012
Blow N (2007) Microfluidics: in search of a killer application. Nat Meth 4:665–670
Blow N (2009) Microfluidics: the great divide. Nat Meth 6:683–686
Becker H (2009) Hype, hope and hubris: the quest for the killer application in microfluidics. Lab Chip 9:2119–2122
The Failed Promise of Innovation in the U.S.—BusinessWeek. http://www.businessweek.com/magazine/content/09_24/b4135000953288.htm. Accessed 12 Nov 2012
medco.com®: About Medco, latest news. http://www.medcohealth.com/medco/corporate/home.jsp?ltSess=y&articleID=CorpAlertMedco_physician_use_gen_tests. Accessed 01 Dec 2010
Stanek EJ et al (2012) Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther. 91(3):450–458
F.D.A. Faults 5 Companies on Genetic Tests—NYTimes.com. http://www.nytimes.com/2010/06/12/health/12genome.html. Accessed 12 Nov 2012
Daktari Diagnostics Closes $2.8M Series A Round to Combat Global HIV Crisis | Xconomy. http://www.xconomy.com/boston/2009/09/04/daktari-diagnostics-closes-28m-series-a-round-to-combat-global-hiv-crisis/. Accessed 12 Nov 2012
The Boomerang: Healthcare Innovation Goes Where it Must, To the Developing World « Boston Biotech Watch. http://bostonbiotechwatch.com/2010/05/27/the-boomerang-healthcare-innovation-goes-where-it-must-to-the-developing-world/. Accessed 12 Nov 2012
Russell J (2010) Alere Investor Presentation, BMO Capital Markets 2010 Healthcare Conference. http://investor.alere.com/news/upload/Alere_Investor_presentation_5-Aug-2010.pdf. Accessed 01 Dec 2010
Becker H (2010) Collective wisdom. Lab Chip 10:1351–1354
Lab on a chip and Microfluidic Devices (a.k.a., Microfluidics) | LinkedIn. http://www.linkedin.com/groups?mostPopular=&gid=713657. Accessed 12 Nov 2012
Russell J (2010) Alere Investor Presentation, BMO Capital Markets 2010 Healthcare Conference. http://investor.alere.com/news/upload/Alere_Investor_presentation_5-Aug-2010.pdf. Accessed 01 Dec 2010
Becker H (2010) Collective wisdom. Lab Chip 10:1351–1354
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media,LLC
About this protocol
Cite this protocol
Kim, L. (2013). Overview of the Microfluidic Diagnostics Commercial Landscape. In: Jenkins, G., Mansfield, C. (eds) Microfluidic Diagnostics. Methods in Molecular Biology, vol 949. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-134-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-62703-134-9_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-133-2
Online ISBN: 978-1-62703-134-9
eBook Packages: Springer Protocols